1Weil EH,Ruiz-Cerda JL,Eerdmans PH,et al.Clinical results of sacral neuromodulation for chronic voiding dysfunction using unilateral sacral foramen electrodes[J].World J Urol,1998,16(5):313-321.
2Al-zahrani AA,Elzayat EA,Gajewski JB.Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms:14-year experience at I center[J]. J Urol,2011,185(3):981-986.
3van Kerrebroeck PE,van Voskuilen AC,Heesakkers JP,et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction:outcomes of a prospective,worldwide clinical study [J].J Urol,2007,178(5):2029-2034.
4Kessler TM,La Framboise D,Trelle S,et al.Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis[J].Eur Urol,2010,58(6):865-874.
5Siddiqui NY,Wu JM,Amundsen CL.Efficacy and adverse events of sacral nerve stimulation for overactive bladder:A systematic review[J].Neurourol Urodyn,2010,29 Suppl 1:S18-23.
6Spinelli M,Sievert KD.Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation:impact on treatment success and safety[J].Eur Urol,2008,54(6):1287-1296.
7Doublet JD,Sotto A,Escaravage L,et al.[Guidelines from the Infectious Disease Committee of the French Association of Urology and The Neuro-Urology Committee of the AFU antibiotic prophylaxis for sacral neuromodulation][J].Prog Urol,2013,23(10):849-855.
8Haraway AM,Clemens JQ,He C,et al.Differences in sacral neuromodulation device infection rates based on preoperative antibiotic selection[J].Int Urogynecol J,2013,24(12):2081-2085.
9Hijaz A,Vasavada SP,Daneshgari F,et al.Complications and troubleshooting of two-stage sacral neuromodulation therapy:a single-institution experience[J].Urology,2006,68(3):533-537.
10Leong RK,De Wachter SG,Nieman FH,et al.PNE versus 1st stage tined lead procedure:a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy[J].Neurourol Urodyn,2011,30(7):1249-1252.
